Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer.

× No keyword cloud information.

28 in total

1. Triple negative mixed metaplastic breast carcinoma with squamous and spindle cells in an 84-year-old woman: a rare entity with unclear management strategy and poor prognosis.

Authors: Srujitha Murukutla; Vijaya Raj Bhatt; Abhirami Vivekanandarajah; Cynara Coomer; Shilpi Gupta
Journal: BMJ Case Rep Date: 2012-02-25

Review 2. Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review.

Authors: Priyanka Singh; Veerandra Kumar; Sonu Kumar Gupta; Gudia Kumari; Malkhey Verma
Journal: Med Oncol Date: 2021-01-16 Impact factor: 3.064

3. Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer.

Authors: S Moulder; T Helgason; F Janku; J Wheler; J Moroney; D Booser; C Albarracin; P K Morrow; J Atkins; K Koenig; M Gilcrease; R Kurzrock
Journal: Ann Oncol Date: 2015-04-15 Impact factor: 32.976

Review 4. Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy.

Authors: Sausan Abouharb; Stacy Moulder
Journal: Curr Oncol Rep Date: 2015-03 Impact factor: 5.075

5. Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents.

Authors: Prasanth Ganesan; Stacy Moulder; J Jack Lee; Filip Janku; Vicente Valero; Ralph G Zinner; Aung Naing; Siqing Fu; Apostolia M Tsimberidou; David Hong; Bettzy Stephen; Philip Stephens; Roman Yelensky; Funda Meric-Bernstam; Razelle Kurzrock; Jennifer J Wheler
Journal: Mol Cancer Ther Date: 2014-09-24 Impact factor: 6.261

6. Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.

Authors: Reva K Basho; Clinton Yam; Michael Gilcrease; Rashmi K Murthy; Thorunn Helgason; Daniel D Karp; Funda Meric-Bernstam; Kenneth R Hess; Vicente Valero; Constance Albarracin; Jennifer K Litton; Mariana Chavez-MacGregor; David Hong; Razelle Kurzrock; Gabriel N Hortobagyi; Filip Janku; Stacy L Moulder
Journal: Oncologist Date: 2018-08-23

7. Multicentric Metaplastic Breast Carcinoma with Squamous Differentiation.

Authors: Sunil Vitthalrao Jagtap; Suresh J Bhosale; P G Chougule; Shrutika D Dhawan; Dhiraj Shukla
Journal: J Clin Diagn Res Date: 2015-07-01

8. Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations.

Authors: Prasanth Ganesan; Filip Janku; Aung Naing; David S Hong; Apostolia M Tsimberidou; Gerald S Falchook; Jennifer J Wheler; Sarina A Piha-Paul; Siqing Fu; Vanda M Stepanek; J Jack Lee; Rajyalakshmi Luthra; Michael J Overman; E Scott Kopetz; Robert A Wolff; Razelle Kurzrock
Journal: Mol Cancer Ther Date: 2013-10-03 Impact factor: 6.261

Review 9. Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review.

Authors: F Giugliano; J Uliano; V A A Zia; D Trapani; A Marra; G Viale; E Ferraro; A Esposito; C Criscitiello; P D'amico; G Curigliano
Journal: Breast Cancer Res Treat Date: 2021-05-27 Impact factor: 4.872

Review 10. Targeted therapy in rare cancers--adopting the orphans.

Authors: Javier Munoz; Razelle Kurzrock
Journal: Nat Rev Clin Oncol Date: 2012-09-11 Impact factor: 66.675